LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

DCF Advisers, LLC's Holding History (CIK: 0001802493)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 107,751 Value ($000) $54 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 107,751 Value ($000) $98 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 107,751 Value ($000) $107 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 107,751 Value ($000) $159 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 94,751 Value ($000) $103 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 82,751 Value ($000) $98 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 15,000 Value ($000) $21 Avg Close $1.38 Range $1.24 - $1.57
Q1 2022
Shares 53,000 Value ($000) $82 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 85,000 Value ($000) $208 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 87,000 Value ($000) $219 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 74,500 Value ($000) $212 Avg Close $2.59 Range $2.14 - $3.00
Q1 2021
Shares 21,000 Value ($000) $49 Avg Close $2.40 Range $1.55 - $3.13